sysmex

Net Sales

Net Sales (Consolidated)

¥249.8billion

  • 1968
  • 1976
  • 1984
  • 1992
  • 2000
  • 2008
  • 2016

Fiscal year ended March 31, 2017

Overseas Sales Ratio

82.6%

Fiscal year ended March 31, 2017

Sysmex provides products in

more than 190 countries

Fiscal year ended March 31, 2017

Net Sales by Destination

  • Japan17.4%
  • Americas24.1%
  • EMEA25.9%
  • China24.1%
  • Asia Pacific8.5%

Fiscal year ended March 31, 2017

Business Domains

In Vitro Diagnostics (IVD) essential for healthcare More than 90% of net sales

Fiscal year ended March 31, 2017

Net Sales by Business

  • Others7.0%
  • Life Science1.8%
  • Hemostasis16.4%
  • Clinical chemistry1.4%
  • Immunochemistry3.2%
  • Urinalysis6.4%
  • Hematology63.8%

Global Market Share

No. 1in the three fields of hematology, hemostasis and sediment urinalysisin the three fields of hematology, hemostasis and sediment urinalysis

Sysmex research

  • Hematology
  • Hemostasis (including alliances)
  • Urinalysis(sediment)
  • … Sysmex
  • … Other companies

Number of Employees

More than 8,400 people worldwide

Including non-regular and part-time employees and others (As of December 31, 2017)

Employees by Region

  • Asia Pacific
  • China
  • EMEA
  • Americas
  • Japan

Global Network

72 subsidiaries and affiliates in 43 countries

Including associated companies accounted for by the equity method (As of December 31, 2017)

  • Japan

     

    11 companies

  • Overseas

     

    61 companies

  • … Sysmex Corporation (Head office)
  • … Regional headquarters
  • … Other subsidiaries and affiliates

*EMEA: Europe, the Middle East and Africa